Taro Pharma (TARO) Appoints New CFO

October 3, 2016 5:08 PM EDT

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced the appointment of Mariano Balaguer as Vice President, CFO and Chief Accounting Officer, effective today.

Mr. Balaguer has nearly 20 years of senior management experience in finance with global companies such as Novartis Consumer Health, Nestle and most recently, the Global Strategic Portfolio Division of Henry Schein (“Henry Schein”).

With Henry Schein, Mr. Balaguer was responsible for the finance functions of the business working to expand the investment and profitability of the group as well as further the capabilities of the financial teams. He worked closely with the financial leaders of Henry Schein’s affiliate companies in all aspects of financial reporting, planning, expense control, tax, treasury, M&A and other financial matters.

Regarding the appointment, Mr. Sundaram, Taro’s CEO, commented, “We are very pleased to have Mariano join the Taro team. His extensive financial background in related industries and his international experience will help strengthen our management team and contribute to the continuing growth and expansion of our business.”

Mr. Balaguer earned a Bachelor’s Degree in Economics from the Universidad Nacional de Cuyo, Argentina and an MBA from New York University Stern School of Business.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Management Changes, Management Comments

Add Your Comment